
Global Antihypertensive Drugs Market 2022-2026
Description
Global Antihypertensive Drugs Market 2022-2026
Technavio has been monitoring the antihypertensive drugs market and it is poised to grow by $5.87 bn during 2022-2026, accelerating at a CAGR of 3.1% during the forecast period. Our report on the antihypertensive drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of a wide range of drugs, the rising population with risk factors for hypertension, and increased funds for research on hypertension.
The antihypertensive drugs market analysis includes type segment and geographic landscape.
Technavio's antihypertensive drugs market is segmented as below:
By Type
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the antihypertensive drugs market covers the following areas:
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Technavio has been monitoring the antihypertensive drugs market and it is poised to grow by $5.87 bn during 2022-2026, accelerating at a CAGR of 3.1% during the forecast period. Our report on the antihypertensive drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of a wide range of drugs, the rising population with risk factors for hypertension, and increased funds for research on hypertension.
The antihypertensive drugs market analysis includes type segment and geographic landscape.
Technavio's antihypertensive drugs market is segmented as below:
By Type
- Systemic hypertension
- Pulmonary hypertension
- North America
- Europe
- Asia
- Rest of World (ROW)
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the antihypertensive drugs market covers the following areas:
- Antihypertensive drugs market sizing
- Antihypertensive drugs market forecast
- Antihypertensive drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
120 Pages
- Market overview
- Market ecosystem
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021-2026
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Type
- Systemic hypertension - Market size and forecast 2021- 2026
- Pulmonary hypertension - Market size and forecast 2021- 2026
- Market opportunity by Type
- Customer landscape overview
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- Rest of World (ROW) - Market size and forecast 2021- 2026
- US - Market size and forecast 2021-2026
- Germany - Market size and forecast 2021-2026
- UK - Market size and forecast 2021-2026
- China - Market size and forecast 2021-2026
- Japan - Market size and forecast 2021-2026
- Market opportunity by geography
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market trends
- Overview
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AstraZeneca Plc
- Bayer AG
- Dr Reddys Laboratories Ltd
- GlaxoSmithKline Plc
- Johnson and Johnson
- Lupin Ltd
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Scope of the report
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.